J. Stephen Morrison, a senior vice president at the CSIS Global Health Policy Center, sheds light on the recent outbreak of a deadlier Mpox variant in the Democratic Republic of the Congo. He discusses the virus's origins and its mislabeling, delves into the challenges of public health responses amidst political hysteria, and outlines urgent interventions needed as cases rise in Africa. Morrison emphasizes the importance of vaccinations and international health coordination to combat this growing concern.
The recent Mpox outbreak in Africa, particularly the deadly clade 1B variant, highlights the urgent need for enhanced public health interventions and vaccination efforts.
The socio-political implications of a potential Mpox spread to the U.S. underscore the importance of preparedness and accurate information dissemination during health crises.
Deep dives
Overview of Monkeypox and Historical Context
Monkeypox, a virus related to smallpox, was first identified in 1958 during an outbreak among laboratory monkeys in Denmark, although it primarily spreads from rodents in Africa. Historically, monkeypox has been considered a low-grade viral outbreak with limited human-to-human transmission, usually emerging from zoonotic sources like bushmeat. The virus's name was revised in 2022 to 'MPOX' to avoid perpetuating racist stereotypes associated with its origins. Recent years have witnessed a significant shift in its transmission dynamics, particularly with a notable outbreak among certain communities, prompting the World Health Organization to declare a global health emergency.
The Changing Landscape of Monkeypox Transmission
The recent surge of monkeypox cases, particularly in Africa, is marked by a dangerous mutation known as clade 1B, which has a mortality rate of 3% to 4%, significantly higher than the 0.2% mortality associated with previous outbreaks. This variant is becoming endemic with increased human-to-human transmission, including cases among children and unsuspecting adults through close contact. The outbreak is exacerbated by a lack of vaccination in populations under 36 years old, following the cessation of smallpox vaccinations, and horrific public health conditions in affected areas. Consequently, diseases like measles and cholera complicate the health landscape, creating a perfect storm for rapid virus spread.
Global Response and Preparedness Measures
In reaction to the escalating situation, public health authorities are enhancing surveillance and intervention efforts, especially in Africa, where the outbreak is currently concentrated. The CDC has been proactive, stressing the need for preparedness, particularly as clade 1B cases are expected to emerge outside of Africa. Amid this, there is an acknowledgment of the possible socio-political ramifications if monkeypox enters the U.S. during a politically charged climate. The deployment of vaccines and better diagnostics are critical facets of the strategy, aimed at curbing the outbreak effectively and preventing panic and misinformation.
J. Stephen Morrison, CSIS Senior Vice President and director of the CSIS Global Health Policy Center, joins the podcast to discuss the recent outbreak of a new, deadlier variant of Mpox in the Democratic Republic of the Congo.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode